These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 594075)

  • 1. Synergistic suppression of the hyperacute form of experimental allergic encephalomyelitis by tilorone and cycloleucine.
    Levine S; Sowinski R
    Proc Soc Exp Biol Med; 1977 Dec; 156(3):457-60. PubMed ID: 594075
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of experimental allergic encephalomyelitis by tilorone: cell transfer and interferon studies.
    Levine S; Sowinski R; Abreu SL
    Immunopharmacology; 1983 Jun; 6(1):23-30. PubMed ID: 6223898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrotic myelopathy (myelomalacia) in rats with allergic encephalomyelitis treated with tilorone.
    Levine S; Sowinski R
    Am J Pathol; 1976 Feb; 82(2):381-92. PubMed ID: 1082719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs.
    Levine S; Sowinski R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):309-18. PubMed ID: 603323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental allergic encephalomyelitis--clinical aspects and treatment].
    Błaszczyk B
    Postepy Hig Med Dosw; 1979; 33(1):77-88. PubMed ID: 86987
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cycloleucine on macrophages and on experimental allergic encephalomyelitis.
    Levine S; Sowinski R
    Exp Mol Pathol; 1977 Feb; 26(1):103-12. PubMed ID: 299848
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of allografts in animals with a new agent: tilorone.
    Wildstein A; Stevens L; Applebaum H; McCabe R; Hashim G; Fitzpatrick H
    Proc Clin Dial Transplant Forum; 1975 Nov; 5():47-50. PubMed ID: 785462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tilorone hydrochloride on experimental flavivirus infections in mice.
    Vargin VV; Zschiesche W; Semenov BF
    Acta Virol; 1977 Mar; 21(2):114-8. PubMed ID: 17279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The suppression of experimental allergic encephalomyelitis by heterologous antilymphocyte serum and antimetabolites].
    Fischer W; Müller J
    Acta Biol Med Ger; 1970; 25(1):197-200. PubMed ID: 5489676
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulated autoantibody response and increased longevity in NZB/NZW mice treated with cyclophosphamide and tilorone.
    Walker SE; Anver MR
    Clin Exp Immunol; 1978 Sep; 33(3):453-62. PubMed ID: 737897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of tilorone on experimental rat silicosis].
    Cheng YH; Yu XF; Liu FY; Han SL; Hou YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Feb; 5(1):25-8. PubMed ID: 6194906
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity of tilorone hydrochloride on a transplantable rat adenocarcinoma.
    Kellen JA; Mirakian A
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):185-8. PubMed ID: 7291725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant polyarthritis. II. Suppression by tilorone.
    Chang YH
    J Pharmacol Exp Ther; 1977 Oct; 203(1):156-61. PubMed ID: 909049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic growth inhibiting effect of nitrous oxide and cycloleucine in experimental rat leukaemia.
    Kroes AC; Lindemans J; Abels J
    Br J Cancer; 1984 Dec; 50(6):793-800. PubMed ID: 6498076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of lymphoid tissues by tilorone. Ultrastructure and synergistic interaction with antilymphocyte serum.
    Levine S; Cacho P; Sowinski R; Thelmo WL
    Am J Pathol; 1983 May; 111(2):174-83. PubMed ID: 6601914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of tilorone on carcinogenesis of the esophagus by N-nitrososarcosine ethylester in rats (author's transl)].
    Cai HY; Lin PZ; Guan XJ; Han R; Zhu TX; Gu QM
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):186-9. PubMed ID: 553794
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tilorone, a synthetic immunostimulator possessing antitumor activity].
    Kavetskiĭ RE; Balitskiĭ KP; Veksler IG; Vetrova EP; Vorontsova AL
    Vopr Onkol; 1977; 23(11):88-93. PubMed ID: 413265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of tilorone on mycobacterial infections of mice.
    Levy L; Aizer F; Ng H; Welch TM
    Lepr Rev; 1978 Sep; 49(3):215-22. PubMed ID: 357869
    [No Abstract]   [Full Text] [Related]  

  • 20. Tilorone-mediated protection against murine B16 melanoma.
    Turner EV; Wallace JH
    Proc Soc Exp Biol Med; 1981 Sep; 167(4):536-41. PubMed ID: 7279931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.